TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Homo sapiens (Human))
Astellas Pharma
US Patent
Astellas Pharma
US Patent
Affinity DataEC50: 3.00E+3nMT: 2°CAssay Description:The activity of sGC was evaluated by measuring the amount of a cyclic guanosine monophosphate (cGMP) which is produced by human purified sGC. A test ...More data for this Ligand-Target Pair
TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Homo sapiens (Human))
Astellas Pharma
US Patent
Astellas Pharma
US Patent
Affinity DataEC50: 4.10E+3nMT: 2°CAssay Description:The activity of sGC was evaluated by measuring the amount of a cyclic guanosine monophosphate (cGMP) which is produced by human purified sGC. A test ...More data for this Ligand-Target Pair
TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Homo sapiens (Human))
Astellas Pharma
US Patent
Astellas Pharma
US Patent
Affinity DataEC50: 2.90E+3nMT: 2°CAssay Description:The activity of sGC was evaluated by measuring the amount of a cyclic guanosine monophosphate (cGMP) which is produced by human purified sGC. A test ...More data for this Ligand-Target Pair
TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Homo sapiens (Human))
Astellas Pharma
US Patent
Astellas Pharma
US Patent
Affinity DataEC50: 1.10E+4nMT: 2°CAssay Description:The activity of sGC was evaluated by measuring the amount of a cyclic guanosine monophosphate (cGMP) which is produced by human purified sGC. A test ...More data for this Ligand-Target Pair
TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Homo sapiens (Human))
Astellas Pharma
US Patent
Astellas Pharma
US Patent
Affinity DataEC50: 2.70E+3nMT: 2°CAssay Description:The activity of sGC was evaluated by measuring the amount of a cyclic guanosine monophosphate (cGMP) which is produced by human purified sGC. A test ...More data for this Ligand-Target Pair
TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Homo sapiens (Human))
Astellas Pharma
US Patent
Astellas Pharma
US Patent
Affinity DataEC50: 6.70E+3nMT: 2°CAssay Description:The activity of sGC was evaluated by measuring the amount of a cyclic guanosine monophosphate (cGMP) which is produced by human purified sGC. A test ...More data for this Ligand-Target Pair
TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Homo sapiens (Human))
Astellas Pharma
US Patent
Astellas Pharma
US Patent
Affinity DataEC50: 2.40E+3nMT: 2°CAssay Description:The activity of sGC was evaluated by measuring the amount of a cyclic guanosine monophosphate (cGMP) which is produced by human purified sGC. A test ...More data for this Ligand-Target Pair
TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Homo sapiens (Human))
Astellas Pharma
US Patent
Astellas Pharma
US Patent
Affinity DataEC50: 6.10E+3nMT: 2°CAssay Description:The activity of sGC was evaluated by measuring the amount of a cyclic guanosine monophosphate (cGMP) which is produced by human purified sGC. A test ...More data for this Ligand-Target Pair
TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Homo sapiens (Human))
Astellas Pharma
US Patent
Astellas Pharma
US Patent
Affinity DataEC50: 4.50E+3nMT: 2°CAssay Description:The activity of sGC was evaluated by measuring the amount of a cyclic guanosine monophosphate (cGMP) which is produced by human purified sGC. A test ...More data for this Ligand-Target Pair
TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Homo sapiens (Human))
Astellas Pharma
US Patent
Astellas Pharma
US Patent
Affinity DataEC50: 1.30E+4nMT: 2°CAssay Description:The activity of sGC was evaluated by measuring the amount of a cyclic guanosine monophosphate (cGMP) which is produced by human purified sGC. A test ...More data for this Ligand-Target Pair
TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Homo sapiens (Human))
Astellas Pharma
US Patent
Astellas Pharma
US Patent
Affinity DataEC50: 6.90E+3nMT: 2°CAssay Description:The activity of sGC was evaluated by measuring the amount of a cyclic guanosine monophosphate (cGMP) which is produced by human purified sGC. A test ...More data for this Ligand-Target Pair
TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Homo sapiens (Human))
Astellas Pharma
US Patent
Astellas Pharma
US Patent
Affinity DataEC50: 2.40E+3nMT: 2°CAssay Description:The activity of sGC was evaluated by measuring the amount of a cyclic guanosine monophosphate (cGMP) which is produced by human purified sGC. A test ...More data for this Ligand-Target Pair
TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Homo sapiens (Human))
Astellas Pharma
US Patent
Astellas Pharma
US Patent
Affinity DataEC50: 2.60E+3nMT: 2°CAssay Description:The activity of sGC was evaluated by measuring the amount of a cyclic guanosine monophosphate (cGMP) which is produced by human purified sGC. A test ...More data for this Ligand-Target Pair
TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Homo sapiens (Human))
Astellas Pharma
US Patent
Astellas Pharma
US Patent
Affinity DataEC50: 7.30E+3nMT: 2°CAssay Description:The activity of sGC was evaluated by measuring the amount of a cyclic guanosine monophosphate (cGMP) which is produced by human purified sGC. A test ...More data for this Ligand-Target Pair
TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Homo sapiens (Human))
Astellas Pharma
US Patent
Astellas Pharma
US Patent
Affinity DataEC50: 1.70E+4nMT: 2°CAssay Description:The activity of sGC was evaluated by measuring the amount of a cyclic guanosine monophosphate (cGMP) which is produced by human purified sGC. A test ...More data for this Ligand-Target Pair
TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Homo sapiens (Human))
Astellas Pharma
US Patent
Astellas Pharma
US Patent
Affinity DataEC50: 1.90E+4nMT: 2°CAssay Description:The activity of sGC was evaluated by measuring the amount of a cyclic guanosine monophosphate (cGMP) which is produced by human purified sGC. A test ...More data for this Ligand-Target Pair
TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Homo sapiens (Human))
Astellas Pharma
US Patent
Astellas Pharma
US Patent
Affinity DataEC50: 1.50E+4nMT: 2°CAssay Description:The activity of sGC was evaluated by measuring the amount of a cyclic guanosine monophosphate (cGMP) which is produced by human purified sGC. A test ...More data for this Ligand-Target Pair
TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Homo sapiens (Human))
Astellas Pharma
US Patent
Astellas Pharma
US Patent
Affinity DataEC50: 6.20E+3nMT: 2°CAssay Description:The activity of sGC was evaluated by measuring the amount of a cyclic guanosine monophosphate (cGMP) which is produced by human purified sGC. A test ...More data for this Ligand-Target Pair
TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Homo sapiens (Human))
Astellas Pharma
US Patent
Astellas Pharma
US Patent
Affinity DataEC50: 1.10E+4nMT: 2°CAssay Description:The activity of sGC was evaluated by measuring the amount of a cyclic guanosine monophosphate (cGMP) which is produced by human purified sGC. A test ...More data for this Ligand-Target Pair
TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Homo sapiens (Human))
Astellas Pharma
US Patent
Astellas Pharma
US Patent
Affinity DataEC50: 1.10E+4nMT: 2°CAssay Description:The activity of sGC was evaluated by measuring the amount of a cyclic guanosine monophosphate (cGMP) which is produced by human purified sGC. A test ...More data for this Ligand-Target Pair
TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Homo sapiens (Human))
Astellas Pharma
US Patent
Astellas Pharma
US Patent
Affinity DataEC50: 4.70E+3nMT: 2°CAssay Description:The activity of sGC was evaluated by measuring the amount of a cyclic guanosine monophosphate (cGMP) which is produced by human purified sGC. A test ...More data for this Ligand-Target Pair
TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Homo sapiens (Human))
Astellas Pharma
US Patent
Astellas Pharma
US Patent
Affinity DataEC50: 2.20E+3nMT: 2°CAssay Description:The activity of sGC was evaluated by measuring the amount of a cyclic guanosine monophosphate (cGMP) which is produced by human purified sGC. A test ...More data for this Ligand-Target Pair
TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Homo sapiens (Human))
Astellas Pharma
US Patent
Astellas Pharma
US Patent
Affinity DataEC50: 5.90E+3nMT: 2°CAssay Description:The activity of sGC was evaluated by measuring the amount of a cyclic guanosine monophosphate (cGMP) which is produced by human purified sGC. A test ...More data for this Ligand-Target Pair
TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Homo sapiens (Human))
Astellas Pharma
US Patent
Astellas Pharma
US Patent
Affinity DataEC50: 1.70E+4nMT: 2°CAssay Description:The activity of sGC was evaluated by measuring the amount of a cyclic guanosine monophosphate (cGMP) which is produced by human purified sGC. A test ...More data for this Ligand-Target Pair
TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Homo sapiens (Human))
Astellas Pharma
US Patent
Astellas Pharma
US Patent
Affinity DataEC50: 3.00E+3nMT: 2°CAssay Description:The activity of sGC was evaluated by measuring the amount of a cyclic guanosine monophosphate (cGMP) which is produced by human purified sGC. A test ...More data for this Ligand-Target Pair
TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Homo sapiens (Human))
Astellas Pharma
US Patent
Astellas Pharma
US Patent
Affinity DataEC50: 5.40E+3nMT: 2°CAssay Description:The activity of sGC was evaluated by measuring the amount of a cyclic guanosine monophosphate (cGMP) which is produced by human purified sGC. A test ...More data for this Ligand-Target Pair
TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Homo sapiens (Human))
Astellas Pharma
US Patent
Astellas Pharma
US Patent
Affinity DataEC50: 1.50E+4nMT: 2°CAssay Description:The activity of sGC was evaluated by measuring the amount of a cyclic guanosine monophosphate (cGMP) which is produced by human purified sGC. A test ...More data for this Ligand-Target Pair
TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Homo sapiens (Human))
Astellas Pharma
US Patent
Astellas Pharma
US Patent
Affinity DataEC50: 6.30E+3nMT: 2°CAssay Description:The activity of sGC was evaluated by measuring the amount of a cyclic guanosine monophosphate (cGMP) which is produced by human purified sGC. A test ...More data for this Ligand-Target Pair
TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Homo sapiens (Human))
Astellas Pharma
US Patent
Astellas Pharma
US Patent
Affinity DataEC50: 8.90E+3nMT: 2°CAssay Description:The activity of sGC was evaluated by measuring the amount of a cyclic guanosine monophosphate (cGMP) which is produced by human purified sGC. A test ...More data for this Ligand-Target Pair
TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Homo sapiens (Human))
Astellas Pharma
US Patent
Astellas Pharma
US Patent
Affinity DataEC50: 8.60E+3nMT: 2°CAssay Description:The activity of sGC was evaluated by measuring the amount of a cyclic guanosine monophosphate (cGMP) which is produced by human purified sGC. A test ...More data for this Ligand-Target Pair
TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Homo sapiens (Human))
Astellas Pharma
US Patent
Astellas Pharma
US Patent
Affinity DataEC50: 5.60E+3nMT: 2°CAssay Description:The activity of sGC was evaluated by measuring the amount of a cyclic guanosine monophosphate (cGMP) which is produced by human purified sGC. A test ...More data for this Ligand-Target Pair
TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Homo sapiens (Human))
Astellas Pharma
US Patent
Astellas Pharma
US Patent
Affinity DataEC50: 7.60E+3nMT: 2°CAssay Description:The activity of sGC was evaluated by measuring the amount of a cyclic guanosine monophosphate (cGMP) which is produced by human purified sGC. A test ...More data for this Ligand-Target Pair
TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Homo sapiens (Human))
Astellas Pharma
US Patent
Astellas Pharma
US Patent
Affinity DataEC50: 2.70E+3nMT: 2°CAssay Description:The activity of sGC was evaluated by measuring the amount of a cyclic guanosine monophosphate (cGMP) which is produced by human purified sGC. A test ...More data for this Ligand-Target Pair
TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Homo sapiens (Human))
Astellas Pharma
US Patent
Astellas Pharma
US Patent
Affinity DataEC50: 2.80E+3nMT: 2°CAssay Description:The activity of sGC was evaluated by measuring the amount of a cyclic guanosine monophosphate (cGMP) which is produced by human purified sGC. A test ...More data for this Ligand-Target Pair